Breaking news – Pagina 147 – AMD

Breaking news

Novembre 24, 2023 dario.olivero

Diabetic ketoacidosis (DKA) at diagnosis in youth with type 1 diabetes (T1D) is associated with a higher hemoglobin A1c even with intensive insulin management

Zaharieva DP, Ding V, Addala A, et al.
Diabetes Technol Ther. Pub. online 13 Nov 2023.

Leggi

Novembre 24, 2023 dario.olivero

The cardiovascular effects of novel weight loss therapies

Usman MS, Davies M, Hall ME, et al.
European Heart Journal. 2023;ehad664.

Leggi

Novembre 24, 2023 dario.olivero

Non‐alcoholic fatty liver disease is associated with brain function disruption in type 2 diabetes patients without cognitive impairment

Li X, Zhang W, Bi Y, et al.
Diabetes Obes Metab. Pub. online 14 Nov 2023.

Leggi

Novembre 17, 2023 dario.olivero

Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT‐1 post hoc analysis

Hankosky ER, Wang H, Neff LM, et al.
Diabetes Obes Metab. Pub. online 6 Nov 2023.

Leggi

Novembre 17, 2023 dario.olivero

Evaluating the effect of a digital health intervention to enhance physical activity in people with chronic kidney disease (Kidney BEAM): a multicentre, randomised controlled trial in the UK

Greenwood SA, Young HML, Briggs J, et al.
Lancet Digit Health. 2023:S2589-7500(23)00204-2.

Leggi

Novembre 17, 2023 dario.olivero

Ascertainment of minimal clinically important differences in the diabetes distress scale–17: a secondary analysis of a randomized clinical trial

Banks J, Amspoker AB, Vaughan EM, et al.
JAMA Netw Open. 2023;6(11):e2342950.

Leggi

Novembre 17, 2023 dario.olivero

Type 2 diabetes and colorectal cancer risk

Lawler T, Walts ZL, Steinwandel M, et al.
JAMA Netw Open. 2023;6(11):e2343333.

Leggi

Novembre 17, 2023 dario.olivero

Global trends in the burden of chronic kidney disease attributable to type 2 diabetes: an age‐period‐cohort analysis

Liu W, Zhang D, Wang R, et al.
Diabetes Obes Metab. Pub. online 7 Nov 2023.

Leggi

Novembre 17, 2023 dario.olivero

Glomerular and tubular effects of dapagliflozin, eplerenone and their combination in patients with chronic kidney disease: A post‐hoc analysis of the ROTATE‐3 study

Lieverse TTGF, Puchades MJ, Mulder UDJ, et al.
Diabetes Obes Metab. Pub. online 5 Nov 2023.

Leggi

Novembre 13, 2023 dario.olivero

A randomised controlled trial assessing the impact of CGM with a predictive hypoglycaemia alert function on hypoglycaemia in physical activity for people with type 1 diabetes (PACE)

Rilstone SK, Oliver N, Godsland IF, et al.
Diabetes Technol Ther. Pub. online 9 Nov 2023.

Leggi